Trial Identifiers
Use the hyperlinks, where available to access additional clinical trial information.
Trial sponsor
Bayer Inc
Scientific Title
A Phase 1/2 Study of the TRK Inhibitor LOXO-195 in Adult and Pediatric Subjects With Previously Treated NTRK Fusion Cancers